Frank Perabo is a seasoned biotech and pharma executive with over 20 years of experience in preclinical and clinical drug development. They currently serve as Chairperson of the Board at Dvant Pharma, focusing on the development of a transformative therapy in oncology, and as VP of Clinical Development at MacroGenics. Previously, Frank held several leadership roles, including Chief Executive Officer at Tachyon Therapeutics and Chief Medical Officer at ESSA Pharma. Their medical training includes a Doctor of Medicine from Ludwig-Maximilians-Universität München and a Doctor of Philosophy from the Technical University of Munich. Frank has a proven track record in driving global regulatory compliance and business strategy in the drug development landscape.
This person is not in any teams
This person is not in any offices